Amarin Corp Plc (AMRN)

[jessellivermore]

anfla...

1) no one has a legal right to infringe on a valid US patent.That include generics, drug plans..you name it..The drug dealers can only substitute for the MARINE label...And the substitution will be gen Lovaza because it is cheaper and has the same label indications and usage as the MARINE Vascepa label..ie The generics Vascepa...The generics right now have only won the right to sell Vascepa for the MARINE high trig indication,,

If the drug plans or pharmacies substitute Gen Lovaza for Amarin's R-I Vascepa.. They will be infringing on Amarin's valid patents. The generics Vascepa is by definition only legal for the MARINE indication. The generics know this and can not market this for the ANCHOR Dec/2019 label expansion,

The drug sellers can not substitute gen Lovaza for R-I Vascepa because Gen Lovaza does not have the same FDA Label indications and usage..Right now only Amarin has the right in the USA to market and sell R-I Vascepa for the R-I indication..Drug plans and pharmacies can not substitute Gen V or Gen L for Amarin's Vascepa if it is prescribed for CVD event risk..To do so they would be inducing infringement.

":>) JL